| Financial Year |
March 31 2023 |
| Monetary Funds |
1,005,919,835.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
38,313,371.85 |
| Accounts Receivable |
1,251,474,192.55 |
| Advances to Suppliers |
39,906,590.90 |
| Other Receivables |
70,530,241.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
541,477,789.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,818,582.90 |
| Total Current Assets |
3,100,881,761.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,535,839.32 |
| Investment Properties |
13,305,898.42 |
| Fixed Assetes |
524,009,413.28 |
| Under-construction Projects |
15,706,778.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
92,748,713.43 |
| R&D expenses |
-- |
| Goodwill |
762,114,518.83 |
| Long-Term Deferred and Prepaid Expenses |
16,904,165.69 |
| Deferred Income Tax Assets |
141,043,933.81 |
| Other Non-Current Assets |
34,206,026.59 |
| Sub-Total of Non-Current Assets |
2,347,189,932.86 |
| Total Assets |
5,448,071,694.53 |
| Short-Term Loans |
303,768,023.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
90,750,000.00 |
| Accounts Payable |
995,144,584.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
60,910,739.67 |
| Taxes Payable |
131,692,065.92 |
| Interest Payable |
-- |
| Dividend Payable |
21,026,954.00 |
| Other payables |
493,717,332.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,919,195.58 |
| Other Current Liabilities |
17,528,172.24 |
| Sub-Total of Current Liabilities |
2,334,253,250.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
9,470,878.01 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,380,661.00 |
| Deferred Income Tax Liabilities |
13,092,103.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
87,530,383.80 |
| Total Liabilities |
2,421,783,634.49 |
| Paid-In Capital(Or Share Stock) |
844,262,959.00 |
| Capital Surplus |
685,411,757.32 |
| Surplus Reserve |
160,544,559.65 |
| LESS:Treasury Stock |
263,476,146.44 |
| Undistributed Profits |
1,482,811,416.80 |
| Minority Stockholder's Interest |
116,128,516.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,910,159,543.10 |
| Owner's Equity（Stockholder's Equity） |
3,026,288,060.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,448,071,694.53 |
